Home >> News >> Business >> CountryFocus Healthcare, Regulatory and Reimbursement Landscape – Finland

CountryFocus Healthcare, Regulatory and Reimbursement Landscape – Finland

“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Finland”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Finland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

View full report @ http://www.acutemarketreports.com/report/countryfocus-healthcare-regulatory-and-reimbursement-landscape-finland

Finland is one of the rapidly emerging markets in the EU, with a strong focus on pharmaceutical R&D. It spends approximately 9.4% of its GDP on healthcare. The pharmaceutical market value decreased from $2.50 billion in 2010 to $2.47 billion in 2015 at negative CAGR of 0.26%, owing to an increase in generic volume from 34% in 2010 to 42% in 2015. It is expected to reach $2.65 billion in 2022. However, the market value in terms of Euros was €1.89 billion in 2010 and increased at a CAGR of 3% from 2015. It is expected to reach €2.80 billion in 2022. The Finnish medical device market was valued at $0.99 billion in 2010, which increased to $1.27 billion in 2017. The main segments were cardiovascular devices, diabetes care devices, in vitro diagnostics, orthopedic devices and ophthalmic devices. The increasing elderly population, favorable foreign investment environment and tremendous innovation are expected to drive the growth of the pharmaceutical market. However, generic substitution, increased healthcare expenditure and presence of counterfeit medicines act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, GSK, Sanofi and Orion) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche, DePuy, Zimmer Biomet and Revenio)
Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Finland

Porter’s five forces analysis for pharmaceutical and medical devices market of Finland
An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Finnish healthcare market

View full report @ http://www.acutemarketreports.com/report/countryfocus-healthcare-regulatory-and-reimbursement-landscape-finland

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving the Finnish healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Identify, understand, and capitalize on the opportunities and challenges in the Finnish healthcare market

Leave a Reply

Your email address will not be published. Required fields are marked *